IDARUBICIN
Manner of administration:Injection
Restriction
Indication: Acute myelogenous leukaemia (AML)
Quantities & Cost
| Max amount | # of repeats | DPMA | Max safety net | General Patient Charge |
|---|---|---|---|---|
| Max amount: 30 mg | # of repeats: 5 | DPMA: $270.69 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | ||||
| Zavedos Solution
(idarubicin hydrochloride 5 mg/5 mL injection, 5 mL vial)
|
||||
Manner of administration:Injection
Restriction
Indication: Acute myelogenous leukaemia (AML)
Quantities & Cost
| Max amount | # of repeats | DPMA | Max safety net | General Patient Charge |
|---|---|---|---|---|
| Max amount: 30 mg | # of repeats: 5 | DPMA: $318.88 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | ||||
| Zavedos Solution
(idarubicin hydrochloride 5 mg/5 mL injection, 5 mL vial)
|
||||
